Related Experiment Video
Updated: Jan 16, 2026

05:35
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
Published on: June 6, 2025
1.3K
Periprostatic Nerve Block vs. Intravenous Ibuprofen for Pain Management During Transrectal Prostate Biopsy
1Department of Urology, School of Medicine, University of Gaziantep, 27310 Gaziantep, Turkey.
Annali Italiani Di Chirurgia
|January 15, 2026
Summary
Periprostatic nerve block (PPNB) significantly reduced pain during prostate biopsies compared to intravenous (IV) ibuprofen. PPNB offers a more effective analgesic option for patients undergoing this procedure.
Area of Science:
- Urology
- Pain Management
- Anesthesiology
Background:
- Prostate biopsy is a common procedure associated with patient discomfort.
- Effective pain management is crucial for patient tolerance and procedural success.
- Current analgesic options require further comparative evaluation.
Purpose of the Study:
- To compare the efficacy of intravenous (IV) ibuprofen versus periprostatic nerve block (PPNB) for pain control during prostate biopsies.
- To identify factors influencing pain scores in patients undergoing prostate biopsy.
Main Methods:
- A prospective randomized study involving 128 patients undergoing prostate biopsy.
- Patients were allocated to either IV ibuprofen (Group 1) or PPNB (Group 2).
- Pain was assessed using the Visual Analog Scale (VAS); demographic and clinical data were collected and analyzed.
Main Results:
- PPNB (Group 2) demonstrated significantly lower median VAS scores across all procedural stages compared to IV ibuprofen (Group 1) (p < 0.001).
- No significant differences were observed between groups regarding age, prostate volume, BMI, PI-RADS, or biopsy pathology (p > 0.05).
- In the IV ibuprofen group, prostate-specific antigen (PSA) levels and malignant pathology correlated with higher pain scores.
Conclusions:
- PPNB is a superior analgesic method for prostate biopsies compared to IV ibuprofen.
- IV ibuprofen may serve as an alternative for patients unable or unwilling to receive PPNB.
- Further large-scale studies are recommended to validate these findings.

